Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Lung Neoplasms × alovudine × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1

Conditions

Brain Neoplasms 2 Lung Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Carboplatin 84 pembrolizumab 61 Pemetrexed 61 Cisplatin 55 Paclitaxel 46 Docetaxel 45 Gemcitabine 30 Erlotinib Hydrochloride 22 Nivolumab 21 osimertinib 14 durvalumab 14 Cetuximab 12 130-nm albumin-bound paclitaxel 12 Bevacizumab 11 Gefitinib 10 Etoposide 10 Drug Therapy 10 Injections 9 Radiotherapy 8 Ipilimumab 8 Albumin-Bound Paclitaxel 8 Vinorelbine 7 epacadostat 6 capmatinib 6 Taxes 6 motexafin gadolinium 5 ceritinib 5 atezolizumab 5 Fluorouracil 5 Dexamethasone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00847509 2013-09-27

FLT101

Siemens Molecular Imaging

Phase NA Completed

49 enrolled 4 charts

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡